blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1432803

EP1432803 - FRAGMENTS OF THE HUMAN ZN-ALPHA2-GLYCOPROTEIN AND THEIR USE IN METHODS OF TREATMENT OF OBESITY [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.10.2008
Database last updated on 18.11.2024
Most recent event   Tooltip13.08.2010Lapse of the patent in a contracting state
New state(s): TR		published on 15.09.2010  [2010/37]
Applicant(s)For all designated states
Serono Genetics Institute S.A.
Route Nationale 7
91030 Evry Cedex / FR
[2004/51]
Former [2004/27]For all designated states
GENSET SA
Route Nationale 7
F-91000 Evry / FR
Inventor(s)01 / CHUMAKOV, Ilya
691, rue de la Noue
F-77000 Vaux-le-Penil / FR
02 / GUERASSIMENKO, Oxana
22, rue de la Forêt
F-91490 Milly-La-Forêt / FR
 [2004/40]
Former [2004/27]01 / CHUMAKOV, Ilya
691, rue de la Noue
F-77000 Vaux-le-Penil / FR
02 / GUERASSIMENKO, Oxana
160, avenue du Général Leclerc
F-91160 Gif-sur-Yvette / FR
Representative(s)Merck Serono S.A. Intellectual Property
Zone Industrielle de l'Ouriettaz
1170 Aubonne / CH
[N/P]
Former [2007/29]Merck Serono International S.A. Intellectual Property
Intellectual Property Department 9, chemin des Mines
1202 Geneva / CH
Former [2004/27]Hassa, Jürgen, et al
Serono International S.A., 12, Chemin des Aulx
1228 Plan-les-Ouates / CH
Application number, filing date02777726.703.10.2002
[2004/27]
WO2002IB04598
Priority number, dateUS20010327725P05.10.2001         Original published format: US 327725 P
[2004/27]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO03050281
Date:19.06.2003
Language:EN
[2003/25]
Type: A2 Application without search report 
No.:EP1432803
Date:30.06.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 19.06.2003 takes the place of the publication of the European patent application.
[2004/27]
Type: B1 Patent specification 
No.:EP1432803
Date:12.12.2007
Language:EN
[2007/50]
Search report(s)International search report - published on:EP04.12.2003
ClassificationIPC:C12N15/12, C07K14/47, A61K38/17, A61K48/00, A61P3/04
[2004/27]
CPC:
C07K14/47 (EP,US); A61P3/04 (EP); A61P3/06 (EP);
A61P3/10 (EP); A61P9/10 (EP); A61P9/12 (EP);
A61K38/00 (EP,US); A61K48/00 (EP,US); A61K9/0053 (EP,US);
A61K9/0073 (EP,US); A61K9/4808 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SK,   TR [2004/27]
Extension statesAL06.04.2004
LT06.04.2004
LV06.04.2004
MK06.04.2004
RO06.04.2004
SI06.04.2004
TitleGerman:FRAGMENTE DES HUMANEN ZN-ALPHA2-GLYKOPROTEINS UND DEREN VERWENDUNG IN METHODEN ZUR BEHANDLUNG DER FETTLEIBIGKEIT[2004/27]
English:FRAGMENTS OF THE HUMAN ZN-ALPHA2-GLYCOPROTEIN AND THEIR USE IN METHODS OF TREATMENT OF OBESITY[2004/27]
French:POLYNUCLEOTIDES ET POLYPETIDES GZIP ET LEURS UTILISATIONS[2004/27]
Entry into regional phase06.04.2004National basic fee paid 
06.04.2004Designation fee(s) paid 
06.04.2004Examination fee paid 
Examination procedure06.04.2004Examination requested  [2004/27]
04.06.2004Amendment by applicant (claims and/or description)
29.06.2004Loss of particular rights, legal effect: Claims
05.08.2004Despatch of communication of loss of particular rights: Claims {1}
30.11.2006Despatch of a communication from the examining division (Time limit: M06)
05.06.2007Reply to a communication from the examining division
10.08.2007Communication of intention to grant the patent
30.10.2007Fee for grant paid
30.10.2007Fee for publishing/printing paid
Opposition(s)15.09.2008No opposition filed within time limit [2008/47]
Fees paidRenewal fee
06.04.2004Renewal fee patent year 03
12.10.2005Renewal fee patent year 04
12.10.2006Renewal fee patent year 05
12.10.2007Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY12.12.2007
CZ12.12.2007
EE12.12.2007
FI12.12.2007
SK12.12.2007
TR12.12.2007
BG12.03.2008
GR13.03.2008
PT12.05.2008
[2010/37]
Former [2009/34]CY12.12.2007
CZ12.12.2007
EE12.12.2007
FI12.12.2007
SK12.12.2007
BG12.03.2008
GR13.03.2008
PT12.05.2008
Former [2009/23]CZ12.12.2007
EE12.12.2007
FI12.12.2007
SK12.12.2007
BG12.03.2008
GR13.03.2008
PT12.05.2008
Former [2009/22]CZ12.12.2007
EE12.12.2007
FI12.12.2007
SK12.12.2007
GR13.03.2008
PT12.05.2008
Former [2009/13]CZ12.12.2007
FI12.12.2007
SK12.12.2007
GR13.03.2008
PT12.05.2008
Former [2008/42]CZ12.12.2007
FI12.12.2007
SK12.12.2007
PT12.05.2008
Former [2008/39]CZ12.12.2007
FI12.12.2007
SK12.12.2007
Former [2008/36]CZ12.12.2007
FI12.12.2007
Former [2008/25]FI12.12.2007
Cited inInternational search[XY]WO9962939  (TISDALE MICHAEL JOHN [GB], et al) [X] 3,4 * abstract * * page 3, line 3 - page 13, line 24 * * page 30, line 15 - page 31, line 6 * * page 31, line 17 - page 32, line 2 * * SEQ ID NO: 1; page 45 - page 46 * * page 47 - page 52; claims 1-3,7-15,17-20,30,31 * * page 60; figure 10 * * page 62; figure 12 * [Y] 1,2,5-9;
 [DA]WO0151645  (GENSET SA [FR], et al) [DA] 1-9 * the whole document * * see especially:; page 87 - page 88; example 8 * * page 89 - page 90; example 10 * * page 95; example 16 ** and; page 123; figure 24 *;
 [Y]  - KENNEDY, M.W., "Hydrophobic Ligand Binding by Zn-alpha2-glycoprotein, a Soluble Fat-depleting Factor Related to Major Histocompatibility Complex Proteins", JOURNAL OF BIOLOGICAL CHEMISTRY, (20010914), vol. 276, no. 37, pages 35008 - 35013, XP002230650 [Y] 1,2,5-9 * the whole document *

DOI:   http://dx.doi.org/10.1074/jbc.C100301200
 [X]  - UEYAMA, H. ET AL., "Zinc-alpha-2-glycoprotein precursor (Zn-alpha-2-glycoprotein) (Zn-alpha-2-GP)", EMBL, HEIDELBERG, FRG, (19920501), Database accession no. P25311, XP002239682 [X] 3,4 * the whole document *
ExaminationWO03033534
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.